Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$3.27 - $5.65 $1,785 - $3,084
546 Added 50.28%
1,632 $9,000
Q4 2023

Feb 14, 2024

SELL
$2.07 - $4.54 $3,864 - $8,476
-1,867 Reduced 63.22%
1,086 $4,000
Q1 2023

May 15, 2023

SELL
$4.48 - $8.45 $125 - $236
-28 Reduced 0.94%
2,953 $13,000
Q4 2022

Jun 14, 2023

BUY
$5.41 - $8.08 $151 - $226
28 Added 0.95%
2,981 $24.1 Million
Q3 2022

Jun 14, 2023

BUY
$5.17 - $7.11 $144 - $199
28 Added 0.95%
2,981 $16.5 Million
Q3 2022

Mar 30, 2023

BUY
$5.17 - $7.11 $13,462 - $18,514
2,604 Added 690.72%
2,981 $16,000
Q3 2022

Nov 14, 2022

BUY
$5.17 - $7.11 $13,462 - $18,514
2,604 Added 690.72%
2,981 $17,000
Q2 2022

Jun 20, 2023

SELL
$3.41 - $8.95 $8,784 - $23,055
-2,576 Reduced 87.23%
377 $1,000
Q2 2022

Mar 30, 2023

SELL
$3.41 - $8.95 $8,763 - $23,001
-2,570 Reduced 87.21%
377 $1,000
Q2 2022

Aug 11, 2022

SELL
$3.41 - $8.95 $8,763 - $23,001
-2,570 Reduced 87.21%
377 $2,000
Q1 2022

Jun 20, 2023

SELL
$7.78 - $15.31 $46 - $91
-6 Reduced 0.2%
2,947 $24,000
Q1 2022

Mar 30, 2023

SELL
$7.78 - $15.31 $53,573 - $105,424
-6,886 Reduced 70.03%
2,947 $24,000
Q1 2022

May 12, 2022

SELL
$7.78 - $15.31 $53,573 - $105,424
-6,886 Reduced 70.03%
2,947 $24,000
Q4 2021

Jun 21, 2023

BUY
$14.25 - $23.53 $98,040 - $161,886
6,880 Added 232.98%
9,833 $146,000
Q4 2021

Mar 30, 2023

SELL
$14.25 - $23.53 $40,997 - $67,695
-2,877 Reduced 22.64%
9,833 $146,000
Q4 2021

Feb 15, 2022

SELL
$14.25 - $23.53 $40,997 - $67,695
-2,877 Reduced 22.64%
9,833 $146,000
Q3 2021

Jun 21, 2023

BUY
$16.88 - $22.38 $164,698 - $218,361
9,757 Added 330.41%
12,710 $240,000
Q3 2021

Mar 30, 2023

BUY
$16.88 - $22.38 $11,461 - $15,196
679 Added 5.64%
12,710 $240,000
Q3 2021

Nov 15, 2021

BUY
$16.88 - $22.38 $11,461 - $15,196
679 Added 5.64%
12,710 $240,000
Q2 2021

Jun 21, 2023

BUY
$18.03 - $23.82 $163,676 - $216,237
9,078 Added 307.42%
12,031 $223,000
Q2 2021

Mar 30, 2023

BUY
$18.03 - $23.82 $61,175 - $80,821
3,393 Added 39.28%
12,031 $223,000
Q2 2021

Aug 16, 2021

BUY
$18.03 - $23.82 $216,756 - $286,364
12,022 Added 133577.78%
12,031 $224,000
Q1 2021

Jun 26, 2023

BUY
$20.29 - $27.54 $115,348 - $156,564
5,685 Added 192.52%
8,638 $197 Million
Q1 2021

May 14, 2021

SELL
$20.29 - $27.54 $175,082 - $237,642
-8,629 Reduced 99.9%
9 $197,000
Q4 2020

Jun 22, 2023

BUY
$10.16 - $23.98 $57,759 - $136,326
5,685 Added 192.52%
8,638 $187,000
Q3 2020

Jun 26, 2023

BUY
$7.44 - $13.15 $42,296 - $74,757
5,685 Added 192.52%
8,638 $86,000
Q3 2020

Mar 30, 2023

BUY
$7.44 - $13.15 $42,088 - $74,389
5,657 Added 189.77%
8,638 $86,000
Q3 2020

Nov 13, 2020

BUY
$7.44 - $13.15 $64,266 - $113,589
8,638 New
8,638 $87,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $139M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.